News | January 25, 2024
Shilpa Medicare directed to to pay damage to Celltrion
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Subscribe To Our Newsletter & Stay Updated
